What Is A PT Practice Worth?

In 2026, most outpatient PT acquisitions are still priced off normalized earnings durability rather than headline top line. Market-clearing values for independent clinics cluster around 2.5x-4.0x SDE, with a 3.2x median for stable owner-led practices. Revenue and EBITDA multiples remain useful triangulation tools, but realized valuation is primarily determined by therapist productivity, referral reliability, and payer-mix quality.

• SDE is the primary method for owner-operated single-site clinics where owner compensation is normalized into discretionary earnings.
• Revenue multiples are directional only: the 0.6x-1.0x band can materially overvalue low-margin clinics and undervalue operationally efficient sites.
• EBITDA multiples matter most for scale: the 3.0x-5.0x range is more common when leadership depth and reporting controls are established.
• Transfer risk drives final pricing: referral concentration, weak retention systems, and staffing dependence can pull deals toward low-end multiples.

Physical therapy remains an active fragmented healthcare vertical in 2026, supported by aging demographics, musculoskeletal demand, and post-surgical rehab volume. Buyers continue to focus on cash-flow consistency, clinician capacity, and payer resilience as financing costs keep underwriting disciplined.

The 2026 PT buyer field includes clinician acquirers, regional rehab groups, and private-capital-backed platforms. Competitive intensity is highest for clinics with repeatable referral pipelines, strong documentation quality, and sustainable therapist throughput.

• Clinician buyers: generally transact near mid-range SDE multiples with leverage constrained by debt-service coverage.
• Regional operators: pay stronger prices for clinics that can be integrated quickly into centralized billing and credentialing workflows.
• Platform buyers: prioritize leadership redundancy, quality-of-earnings cleanliness, and de novo cluster fit.
• Market variance persists: growth metros with referral density and labor availability clear above slower-growth local markets.
• Staffing stability is a bid differentiator: predictable hiring and therapist retention supports more aggressive offers.

Valuation premiums are earned by clinics that convert demand into repeatable, compliant, and margin-protected throughput. Buyers reward visibility into referral durability and therapist-level production efficiency.

• Productivity discipline: sustained visit volume per therapist with strong cancellation control expands discretionary earnings.
• Referral diversification: lower dependence on any single surgeon group or payer supports higher confidence in post-close performance.
• Digital revenue-cycle strength: tighter authorization workflows and denial management increase realized collections.
• Service-line depth: sports rehab, post-op pathways, and cash-pay programs can raise revenue per therapist and per visit.
• Management infrastructure: consistent KPI reporting improves buyer confidence and reduces diligence discounting.

Most valuation leakage in PT deals stems from execution risk rather than category demand. Multiples compress quickly when buyers identify concentration, compliance, or staffing fragility.

• Therapist concentration risk: overreliance on one high-producing clinician increases post-close attrition risk.
• Referral concentration: dependence on a narrow physician base can reduce confidence in forward revenue durability.
• Payer-mix pressure: heavy low-reimbursement exposure weakens margin stability and leverage capacity.
• Documentation and billing gaps: coding leakage and denial volatility undermine normalized earnings quality.
• Facility and lease constraints: short lease tails or capex needs can directly reduce achieved valuation.

Seller readiness benchmark (2026): owners preparing for exit should normalize add-backs, diversify referral channels, and document therapist productivity by cohort. In the current 2.5x-4.0x SDE framework, these steps can preserve value and improve buyer confidence.